Bokus

Jorge DiMartino – författare

Visar alla böcker från författaren Jorge DiMartino. Handla med fri frakt och snabb leverans.

4 produkter

  1. Jorge DiMartino, Gregory H. Reaman, Franklin O. Smith - Pediatric Cancer Therapeutics Development, Inbunden. Tillgänglighet: Lägg i varukorg

    Pediatric Cancer Therapeutics Development

    Av Jorge DiMartino, Gregory H. Reaman m. fl.

    Inbunden, 2022

    1692 kr

    Lägg i varukorg

    This book provides a comprehensive overview of the scientific, medical, regulatory, and economic considerations associated with the discovery, development, and delivery of novel therapeutics for children with cancer. Co-authored by a diverse team from academic, government, and industry backgrounds, …

  2. Franklin O. Smith, Gregory H. Reaman, Jorge DiMartino - Pediatric Cancer Therapeutics Development, E-bok. Tillgänglighet: Lägg i varukorg

    Pediatric Cancer Therapeutics Development

    Av Franklin O. Smith, Gregory H. Reaman m. fl.

    E-bok, 2022

    1634 kr

    Lägg i varukorg

    This book provides a comprehensive overview of the scientific, medical, regulatory, and economic considerations associated with the discovery, development, and delivery of novel therapeutics for children with cancer. Co-authored by a diverse team from academic, government, and industry backgrounds, …

  3. Jorge DiMartino, Gregory H. Reaman - Pediatric Cancer Therapeutics Development. Tillgänglighet: Lägg i varukorg

    Pediatric Cancer Therapeutics Development

    Av Jorge DiMartino, Gregory H. Reaman

    2022

    665 kr

    Lägg i varukorg

  4. Jorge DiMartino, Gregory H. Reaman, Franklin O. Smith - Pediatric Cancer Therapeutics Development, Häftad. Tillgänglighet: Lägg i varukorg

    Pediatric Cancer Therapeutics Development

    Av Jorge DiMartino, Gregory H. Reaman m. fl.

    Häftad, 2023

    1243 kr

    Lägg i varukorg

    This book provides a comprehensive overview of the scientific, medical, regulatory, and economic considerations associated with the discovery, development, and delivery of novel therapeutics for children with cancer. Co-authored by a diverse team from academic, government, and industry backgrounds, …